Search

Fixed Phage, a Glasgow-based phage biotech company commercialising phage immobilisation and stabilisation-based technology, has secured £2.4 million to scale up its fight against new microbial threats that pose risks to human health and agr

PBD Biotech has secured a £2.3m investment to take Actiphage®, a rapid, accurate phage-based bovine TB test through to validation by the World Organisation for Animal Health. This test has potential to enable farmers to effectively remove T

Armata Pharmaceuticals announced a $20 Million investment to support advancement of its clinical phage development programs. Armata aims to complete a phage clinical trial (Phase 1b/2a, P. aeruginosa) and initiate three more in 2021-2022.

Paris phage biotech company Eligo Bioscience announced a new agreement worth up to $224M with GlaxoSmithKline, which is aimed at advancing Eligobiotics® for acne treatment/prevention. Eligo employs CRISPR-based phage therapeutics for microb

The C-SNIPER project (Campylobacter-Specific Nullification via Innovative Phage-mediated Enteropathogen Reduction), led by AZTI (a technology center in Spain) received funding from the European Institute of Innovation & Technology. The proj

CARB-X is awarding the Indian phage biotech company GangaGen Biotechnologies up to $2.5 Million (with possibility of an additional $8.1 Million if milestones are met) to develop klebicins to treat Klebsiella pneumoniae.

Locus Biosciences signed a $144 million contract with BARDA to support phase II and III clinical trials of LBP-EC01, Locus' CRISPR phage (crPhage™) product.

The Mayo Clinic has invested $1.75 million in Adaptive Phage Therapeutics, which will allow APT to initiate a clinical trial to address periprosthetic joint infections (an estimated commercial market of $900 million per year). The trial is

Eligo Bioscience was awarded funding from CARB-X to develop CRISPR-based phage therapeutics (up to $1.82 million now, and up to $7.05 million if project milestones are met). This is the first CRISPR-based phage project CARB-X has funded.